抗生物質市場レポート：2023-2033

Antibiotics Market Report 2023-2033

レポート詳細抗生物質市場レポート 2023-2033 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなる... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2023年1月31日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	388	367	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

抗生物質市場レポート 2023-2033:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。

世界の抗生物質市場は、感染症の蔓延の増加に起因して成長すると予想されています。また、細菌感染症を治療するための新しい抗生物質の革新的な方法の出現や、多くの臨床試験により、需要が促進されています。しかし、抗生物質の乱用に起因する耐性菌の増加や、規制当局の承認に要する時間などが、この業界の足かせになると予想されます。一方、バリューチェーン全体の市場関係者は、抗生物質耐性微生物（AMR）感染症を治療するための高度な見込み分子と新規併用療法の開発から大きな利益が得られる可能性を期待すべきです。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 抗生物質市場はどのように進化しているのか？
- 抗生物質市場を牽引し、抑制しているものは何か？
- 抗生物質の各サブマーケットセグメントは予測期間中にどのように成長し、2033年にこれらのサブマーケットが占める収益はどの程度になるのか？
- 2023年から2033年にかけて、各抗生物質サブマーケットの市場シェアはどのように推移するのか？
- 2023年から2033年にかけて、市場全体の主な牽引役となるのは何か？
- 主要な抗生物質市場はマクロ経済力学に広く追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しはどうなのか？
- これらの主要企業の抗生物質プロジェクトは何か？
- 2023年から2033年の間に、業界はどのように進化していくのでしょうか？また、その影響はどのようなものでしょうか？
現在、そして今後10年間に実施される抗生物質プロジェクトは？
- 抗生物質市場をさらに拡大するために、製品の商業化の必要性は高まっているのでしょうか？
- 抗生物質市場はどこに向かっているのか、また、市場の最前線に立つためにはどうすればよいのか？
- 新製品やサービスラインへの最適な投資方法は何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが、現在、そして今後10年間の抗生物質市場にどのような影響を与えるかを見極める必要があります。

- 388ページにわたる本レポートでは、144の表と223のチャート/グラフを独占的に提供します。
- 本レポートでは、業界における主要な収益性の高い分野を取り上げているため、今すぐその分野をターゲットにすることができます。
- 世界、地域、国の売上と成長を詳細に分析しています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。

本レポートは、抗生物質市場が今後10年間にどのように発展するか、またCOVID-19の景気後退やバウンスの変化に合わせて、今日あなたにお伝えします。この市場は、過去10年間のどの時点よりも今が重要です。

2033年までの予測やその他の分析により、商業的な展望が見えてきた
- 2033年までの収益予測に加え、直近の実績や成長率、市場シェアなど、本調査では
- ビジネスの展望や展開など、独自の分析がご覧いただけます。
- 定性的分析（市場力学、促進要因、機会、阻害要因など）、ポーターのファイブフォース分析、PEST分析、最近の動向をご覧いただけます。

本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。

報告書の対象セグメント

作用機序
- 細胞壁合成阻害剤
- タンパク質合成阻害剤
- DNA合成阻害剤
- RNA合成阻害剤
- ミコール酸阻害剤
- その他

薬物クラス
- セファロスポリン
- ペニシリン
- フルオロキノロン
- マクロライド
- カルバペネム
- アミノグリコシド
- スルホンアミド
- 7-ACA
- その他

性別
- 男性
- 女性

年齢層
- 0～14歳
- 15-54歳
- 55歳以上

投与経路
- 経口
- 静脈内投与
- その他

世界市場全体とセグメントの収益予測に加え、5つの地域と30の主要国市場の収益予測も掲載しています。

北米
- アメリカ
- カナダ

欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- ロシア
- デンマーク
- ノルウェー
- スウェーデン
- フィンランド
- オランダ
- その他の欧州

アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- シンガポール
- マレーシア
- スリランカ
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他のラテンアメリカ地域

MEA
- GCC
- 南ア
- その他のMEA地域

抗生物質市場の主要企業のプロファイルと2023年から2033年まで、これらの企業の事業のこのセグメントに焦点を当てたものも含まれています。

主要企業と市場成長の可能性
・ Abbott Laboratories
・ Allergan (AbbVie Inc.)
・ Amneal Pharmaceuticals LLC
・ Cipla Ltd.
・ Cumberland Pharmaceuticals, Inc.
・ F. Hoffmann-La Roche Ltd.
・ GSK plc
・ Lupin
・ Melinta Therapeutics LLC
・ Merck ＆ Co., Inc.
・ Novartis AG
・ Pfizer Inc.
・ Sanofi
・ Teva Pharmaceutical Industries Ltd.
・ Viatris, Inc.
・ WOCKHARDT

抗生物質市場の世界全体収益、2023年から2033年まで金額ベースで2023年に465億7500万米ドルを超えると当研究所は算出しています。2033年まで力強い収益成長が予測されます。弊社では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。

抗生物質市場、2023年から2033年までのレポートはどのようにあなたのお役に立ちますか？
380ページを超えるレポートでは、要約すると以下のような知識を得ることができます。

- 抗生物質市場、2023年から2033年までの収益予測、作用機序、薬物クラス、性別、年齢層、投与経路の各予測を世界および地域レベルで掲載 - 業界の展望を発見し、投資と収益のための最も有利な場所を見つけることができます。

- 5つの地域と30の主要国市場の2033年までの収益予測 - 抗生物質市場、2023年から2033年の北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEAの市場予測をご覧ください。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなど、著名な経済圏の市場も予測しています。

- 既存企業および市場参入を目指す企業の展望 - 抗生物質市場に関わる主要企業16社の企業プロファイルを含む、2023年から2033年の市場。

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、抗生物質市場、2023年から2033年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。

ページTOPに戻る

1.レポートの概要
1.1 研究の目的
1.2 抗生物質市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問には以下が含まれます。
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 市場の概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.3 市場の原動力
3.3.1 市場成長を促進する感染症負担の増大
3.3.2 デジタルヘルス技術の導入が抗生物質市場の成長を促進する
3.3.3 高齢化社会の到来による患者数の増加が成長の原動力
3.4 市場の抑制要因
3.4.1 厳しい規制シナリオが市場成長を阻害する
3.4.2 抗生物質耐性の上昇が市場成長の抑制要因に
3.5 市場機会
3.6 SWOT分析
3.6.1 抗生物質市場の長所
3.6.2 抗生物質市場の弱点
3.6.3 抗生物質市場の機会
3.6.4 抗生物質市場の脅威
3.7 産業分析-ポーターズ
3.7.1 買い手の交渉力(低い)
3.7.2 供給者のバーゲニングパワー(低)
3.7.3 競争相手との競合の激しさ(高)
3.7.4 代替品の脅威(低)
3.7.5 新規参入の脅威(低)
3.8 PEST分析
3.8.1 抗生物質市場に影響を与える政治的要因
3.8.1.1 政府のシナリオ
3.8.1.2 閉鎖された市場
3.8.1.3 価格統制
3.8.2 抗生物質市場に影響を与える経済的要因
3.8.2.1 個人所得の増加
3.8.2.2 新薬
3.8.2.3 コスト削減
3.8.3 抗生物質市場に影響を与える社会的要因
3.8.3.1 世代別の健康状態
3.8.3.2 感染性疾患
3.8.3.3 健康意識
3.8.4 抗生物質市場に影響を与える技術的要因
3.8.4.1 バイオテクノロジー産業の成長
3.8.4.2 市場への浸透
3.9 COVID-19の影響分析

4 抗生物質市場分析：作用機序別
4.1 主要な知見
4.2 作用機序セグメント市場魅力度指数
4.3 抗生物質の作用メカニズム別市場規模の推定と予測
4.4 細胞壁合成阻害剤
4.4.1 地域別市場予測、2023年〜2033年 (US$ Mn)
4.4.2 地域別市場シェア、2023年＆2033年(%)
4.5 タンパク質合成阻害剤
4.5.1 地域別市場予測、2023年～2033年 (US$ Mn)
4.5.2 地域別市場シェア、2023年＆2033年(%)
4.6 DNA合成阻害剤
4.6.1 地域別市場予測、2023年～2033年 (US$ Mn)
4.6.2 地域別市場シェア、2023年＆2033年(%)
4.7 RNA合成阻害剤
4.7.1 地域別市場予測、2023年〜2033年 (US$ Mn)
4.7.2 地域別市場シェア、2023年＆2033年(%)
4.8 ミコール酸阻害剤
4.8.1 地域別市場予測、2023年～2033年 (US$ Mn)
4.8.2 地域別市場シェア、2023年＆2033年(%)
4.9 その他
4.9.1 地域別市場予測、2023年〜2033年 (US$ Mn)
4.9.2 地域別市場シェア、2023年＆2033年(%)

5 抗生物質市場分析：薬物クラス別
5.1 主要な調査結果
5.2 薬物クラスセグメント市場魅力度指数
5.3 抗生物質の薬効別市場規模の推定と予測
5.4 セファロスポリン
5.4.1 地域別市場予測、2023年〜2033年 (US$ Mn)
5.4.2 地域別市場シェア、2023年＆2033年(%)
5.5 ペニシリン
5.5.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.5.2 地域別市場シェア、2023年＆2033年(%)
5.6 フルオロキノロン
5.6.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.6.2 地域別市場シェア、2023年＆2033年(%)
5.7 マクロライド
5.7.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.7.2 地域別市場シェア、2023年＆2033年(%)
5.8 カルバペネム
5.8.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.8.2 地域別市場シェア、2023年＆2033年(%)
5.9 アミノグリコシド
5.9.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.9.2 地域別市場シェア、2023年＆2033年(%)
5.10 スルホンアミド
5.10.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.10.2 地域別市場シェア、2023年＆2033年(%)
5.11 7-ACA類
5.11.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.11.2 地域別市場シェア、2023年＆2033年(%)
5.12 その他
5.12.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.12.2 地域別市場シェア、2023年＆2033年(%)

6 抗生物質市場分析：性別
6.1 主な調査結果
6.2 性別別セグメント市場魅力度指数
6.3 抗生物質の性別ごとの市場規模推定と予測
6.4 男性
6.4.1 地域別市場予測、2023年〜2033年 (US$ Mn)
6.4.2 地域別市場シェア、2023年＆2033年(%)
6.5 女性
6.5.1 地域別市場予測、2023年～2033年 (US$ Mn)
6.5.2 地域別市場シェア、2023年＆2033年(%)

7 抗生物質市場分析：年齢層別
7.1 主な調査結果
7.2 年齢層別セグメント市場魅力度指数
7.3 抗生物質の年齢層別市場規模の推定と予測
7.4 0〜14歳
7.4.1 地域別市場予測、2023年〜2033年 (US$ Mn)
7.4.2 地域別市場シェア、2023年＆2033年(%)
7.5 15〜54歳
7.5.1 地域別市場予測、2023年～2033年 (US$ Mn)
7.5.2 地域別市場シェア、2023年＆2033年(%)
7.6 55歳以上
7.6.1 地域別市場予測、2023年～2033年 (US$ Mn)
7.6.2 地域別市場シェア、2023年＆2033年(%)

8 抗生物質市場分析：投与経路別
8.1 主要な調査結果
8.2 投与経路セグメント市場魅力度指数
8.3 抗生物質の投与経路別市場規模の推定と予測
8.4 経口剤
8.4.1 地域別市場予測、2023年〜2033年 (US$ Mn)
8.4.2 地域別市場シェア、2023年＆2033年(%)
8.5 静脈注射
8.5.1 地域別市場予測、2023年～2033年 (US$ Mn)
8.5.2 地域別市場シェア、2023年＆2033年(%)
8.6 その他
8.6.1 地域別市場予測、2023年〜2033年 (US$ Mn)
8.6.2 地域別市場シェア、2023年＆2033年(%)

9 抗生物質市場分析：地域別
9.1 主な調査結果
9.2 地域別市場規模の推定と予測

10 北米の抗生物質市場分析
10.1 主な調査結果
10.2 北米抗生物質市場の魅力度指数
10.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
10.4 国別市場規模推計・予測、2023年～2033年（US$ Mn）
10.5 作用機序別市場規模推計・予測、2023年～2033年（US$ Mn）
10.6 薬物クラス別市場規模推定・予測、2023年～2033年 (US$ Mn)
10.7 性別別市場規模推定・予測、2023年～2033年（US$ Mn)
10.8 年齢層別市場規模推定・予測、2023年～2033年 (US$ Mn)
10.9 投与経路別市場規模推定・予測、2023年～2033年 (US$ Mn)
10.10 米国の抗生物質市場の分析
10.11 カナダの抗生物質市場の分析

11 欧州の抗生物質市場分析
11.1 主な調査結果
11.2 欧州抗生物質市場の魅力度指数
11.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
11.4 国別市場規模推計・予測、2023年～2033年（US$ Mn)
11.5 作用機序別市場規模推計・予測、2023年～2033年（US$ Mn）
11.6 薬物クラス別市場規模推定・予測、2023年～2033年 (US$ Mn)
11.7 性別別市場規模推定・予測、2023年～2033年（US$ Mn)
11.8 年齢層別市場規模推定・予測、2023年～2033年 (US$ Mn)
11.9 投与経路別市場規模推定・予測、2023年～2033年 (US$ Mn)
11.10 ドイツの抗生物質市場の分析
11.11 イギリスの抗生物質市場の分析
11.12 フランスの抗生物質の市場分析
11.13 イタリアの抗生物質の市場分析
11.14 スペイン抗生物質市場の分析
11.15 ロシア抗生物質市場の分析
11.16 デンマークの抗生物質市場の分析
11.17 ノルウェーの抗生物質市場の分析
11.18 スウェーデンの抗生物質市場の分析
11.19 フィンランドの抗生物質市場の分析
11.20 オランダの抗生物質市場の分析
11.21 その他の欧州の抗生物質市場の分析

12 アジア太平洋地域の抗生物質市場分析
12.1 主な調査結果
12.2 アジア太平洋地域の抗生物質市場の魅力度指数
12.3 国別市場規模推定・予測、2023年～2033年（US$ Mn）
12.4 作用機序別市場規模推定・予測、2023-2033年 (US＄ Mn)
12.5 薬物クラス別市場規模推定・予測、2023年～2033年（US$ Mn）
12.6 性別別市場規模推定・予測、2023年～2033年 (US$ Mn)
12.7 年齢層別市場規模推定・予測、2023年～2033年 (US$ Mn)
12.8 投与経路別市場規模推定・予測、2023年～2033年 (US$ Mn)
12.9 日本の抗生物質の市場分析
12.10 中国抗生物質市場の分析
12.11 インドの抗生物質の市場分析
12.12 オーストラリアの抗生物質の市場分析
12.13 シンガポールの抗生物質の市場分析
12.14 マレーシアの抗生物質市場の分析
12.15 スリランカの抗生物質市場の分析
12.16 その他のアジア太平洋地域の抗生物質市場の分析

13 ラテンアメリカの抗生物質市場分析
13.1 主な調査結果
13.2 ラテンアメリカの抗生物質市場魅力度指数
13.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
13.4 国別市場規模推計・予測、2023年～2033年（US$ Mn）
13.5 作用機序別市場規模推計・予測、2023年～2033年（US$ Mn）
13.6 薬物クラス別市場規模推定・予測、2023年～2033年 (US$ Mn)
13.7 性別別市場規模推定・予測、2023年～2033年（US$ Mn)
13.8 年齢層別市場規模推定・予測、2023年～2033年 (US$ Mn)
13.9 投与経路別市場規模推定・予測、2023年～2033年 (US$ Mn)
13.10 ブラジル抗生物質市場の分析
13.11 メキシコの抗生物質市場の分析
13.12 アルゼンチン抗生物質市場の分析
13.13 コロンビアの抗生物質市場の分析
13.14 その他のラテンアメリカの抗生物質市場の分析

14 MEAの抗生物質市場分析
14.1 主な調査結果
14.2 MEA抗生物質市場の魅力度指数
14.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
14.4 国別市場規模推計・予測、2023年～2033年（US$ Mn)
14.5 作用機序別市場規模推計・予測、2023年～2033年（US$ Mn）
14.6 薬物クラス別市場規模推定・予測、2023年～2033年 (US$ Mn)
14.7 性別別市場規模推定・予測、2023年～2033年（US$ Mn)
14.8 年齢層別市場規模推定・予測、2023年～2033年 (US$ Mn)
14.9 投与経路別市場規模推定・予測、2023年～2033年 (US$ Mn)
14.10 GCCの抗生物質市場分析
14.11 南アフリカの抗生物質市場分析
14.12 その他のMEAの抗生物質市場の分析

15 主要企業のプロフィール
15.1 抗生物質市場。企業別ランキング
15.2 抗生物質の主要メーカーがとるべき主要戦略
15.2.1 国際化
15.2.2 製品範囲の拡大
15.2.3 能力開発
15.2.4 コスト差別化
15.2.5 垂直統合
15.3 パイプライン分析
15.4 Abbott Laboratories
15.4.1 会社概要
15.4.2 Abbott Laboratoriesの概要
15.4.3 財務分析
15.4.3.1 純収益、2015-2021年
15.4.3.2 R&D費用、2015-2021年
15.4.3.3 売上総利益、2015年-2021年
15.4.3.4 地域別市場シェア、2021年
15.4.4 製品ベンチマーク
15.4.5 戦略的展望
15.5 F. Hoffmann-La Roche Ltd.
15.5.1 企業スナップショット
15.5.2 会社概要
15.5.3 財務分析
15.5.3.1 純収益、2015-2021年
15.5.3.2 研究開発費、2015年-2021年
15.5.3.3 売上総利益、2015年-2021年
15.5.4 製品ベンチマーク
15.5.5 戦略的な展望
15.6 GSK plc
15.6.1 企業スナップショット
15.6.2 会社概要
15.6.3 財務分析
15.6.3.1 純収益、2015-2021年
15.6.3.2 研究開発費、2015年-2021年
15.6.3.3 売上総利益、2015年-2021年
15.6.3.4 地域別マーケットシェア、2021年
15.6.4 製品ベンチマーク
15.6.5 戦略的展望
15.7 Merck & Co. Inc.
15.7.1 企業スナップショット
15.7.2 会社概要
15.7.3 財務分析
15.7.3.1 純収益、2015-2021年
15.7.3.2 研究開発費、2015年-2021年
15.7.3.3 売上総利益、2015年-2021年
15.7.3.4 地域別市場シェア、2021年
15.7.4 製品ベンチマーク
15.7.5 戦略的展望
15.8 Viatris, Inc. (Mylan)
15.8.1 企業スナップショット
15.8.2 会社概要
15.8.3 財務分析
15.8.3.1 純収益、2015-2021年
15.8.3.2 R&D費用、2015年-2021年
15.8.3.3 売上総利益、2015年-2021年
15.8.3.4 地域別マーケットシェア、2021年
15.8.4 製品ベンチマーク
15.8.5 戦略的展望
15.9 Novartis AG
15.9.1 企業スナップショット
15.9.2 会社概要
15.9.3 財務分析
15.9.3.1 純収益、2015-2021年
15.9.3.2 R&D費用、2015-2021年
15.9.3.3 売上総利益、2015年-2021年
15.9.3.4 地域別マーケットシェア
15.9.4 製品ベンチマーク
15.9.5 戦略的な展望
15.10 Pfizer Inc.
15.10.1 企業スナップショット
15.10.2 会社概要
15.10.3 財務分析
15.10.3.1 純収益、2015-2021年
15.10.3.2 研究開発費、2015年-2021年
15.10.3.3 売上総利益、2015年-2021年
15.10.3.4 地域別マーケットシェア、2021年
15.10.4 製品ベンチマーク
15.10.5 戦略的展望
15.11 Sanofi
15.11.1 企業スナップショット
15.11.2 会社概要
15.11.3 財務分析
15.11.3.1 純収益、2015-2021年
15.11.3.2 R&D費用、2015-2021年
15.11.3.3 売上総利益、2015年-2021年
15.11.3.4 地域別マーケットシェア、2021年
15.11.4 製品ベンチマーク
15.11.5 戦略的な展望
15.12 Teva Pharmaceutical Industries Ltd.
15.12.1 企業スナップショット
15.12.2 会社概要
15.12.3 財務分析
15.12.3.1 純収益、2015-2021年
15.12.3.2 R&D費用、2015-2021年
15.12.3.3 売上総利益、2015年-2021年
15.12.3.4 地域別マーケットシェア、2021年
15.12.4 製品ベンチマーク
15.12.5 戦略的な展望
15.13 Cipla Ltd.
15.13.1 企業スナップショット
15.13.2 会社概要
15.13.3 財務分析
15.13.3.1 純収益、2015-2021年
15.13.4 製品ベンチマーク
15.13.5 戦略的展望
15.14 Allergan (AbbVie Inc.)
15.14.1 企業スナップショット
15.14.2 会社概要
15.14.3 財務分析
15.14.3.1 純収益、2015-2021年
15.14.3.2 R&D費用、2015-2021年
15.14.3.3 売上総利益、2015年-2021年
15.14.3.4 地域別市場シェア、2021年
15.14.4 製品ベンチマーク
15.14.5 戦略的展望
15.15 Cumberland Pharmaceuticals, Inc.
15.15.1 企業スナップショット
15.15.2 会社概要
15.15.3 財務分析
15.15.3.1 純収益、2015-2021年
15.15.3.2 R&D費用、2015-2021年
15.15.3.3 売上総利益、2015年-2021年
15.15.4 製品ベンチマーク
15.15.5 戦略的展望
15.16 Lupin
15.16.1 企業スナップショット
15.16.2 会社概要
15.16.3 製品ベンチマーク
15.16.4 戦略的展望
15.17 Melinta Therapeutics LLC
15.17.1 企業スナップショット
15.17.2 会社概要
15.17.3 製品ベンチマーク
15.17.4 戦略的展望
15.18 Amneal Pharmaceuticals LLC
15.18.1 企業スナップショット
15.18.2 会社概要
15.18.3 財務分析
15.18.3.1 純収益、2015-2021年
15.18.3.2 R&D費用、2015-2021年
15.18.3.3 売上総利益、2015年-2021年
15.18.4 製品ベンチマーク
15.18.5 戦略的展望
15.19 WOCKHARDT
15.19.1 会社概要
15.19.2 会社概要
15.19.3 ベンチマーキング
15.19.4 戦略的展望

16 結論と提言
16.1 ヴィジョンゲインからの結論
16.2 市場関係者への提言

表の一覧
Table 1 Antibiotics Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 7 Cell Wall Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 8 Protein Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 9 DNA Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 10 RNA Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 11 Mycolic Acid Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 12 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 13 Global Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 14 Cephalosporin Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 15 Penicillin Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 16 Fluoroquinolone Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 17 Macrolide Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 18 Carbapenem Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 19 Aminoglycoside Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 20 Sulfonamide Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 21 7-ACA Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 23 Global Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 24 Male Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 25 Female Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 26 Global Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 27 0-14 Years Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 28 15-54 Years Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 29 55 Years and Over Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 30 Global Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 31 Oral Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 32 Intravenous Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 33 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 34 Global Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%)
Table 35 North America Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 36 North America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 37 North America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 38 North America Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 39 North America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 40 North America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 41 U.S. Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 42 Canada Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 43 Europe Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 44 Europe Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 45 Europe Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 46 Europe Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 47 Europe Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 48 Europe Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 49 Germany Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 50 UK Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 51 France Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 52 Italy Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 53 Spain Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 54 Russia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 55 Denmark Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 56 Norway Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 57 Sweden Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 58 Finland Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 59 Netherlands Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 60 Rest of Europe Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 61 APAC Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 62 APAC Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 63 APAC Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 64 APAC Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 65 APAC Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 66 APAC Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 67 Japan Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 68 China Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 69 India Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 70 Australia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 71 Singapore Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 72 Malaysia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 73 Sri Lanka Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 74 Rest of APAC Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 75 Latin America Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 76 Latin America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 77 Latin America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 78 Latin America Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 79 Latin America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 80 Latin America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 81 Brazil Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 82 Mexico Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 83 Argentina Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 84 Colombia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 85 Rest of LATAM Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 86 MEA Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 87 MEA Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 88 MEA Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 89 MEA Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 90 MEA Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 91 MEA Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 92 GCC Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 93 South Africa Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 94 Rest of MEA Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 95 Antibiotics Market: Company Ranking
Table 96 Antibiotics Pipeline Analysis
Table 97 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abbott Laboratories: Product Benchmarking
Table 99 Abbott.: Strategic Outlook
Table 100 Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 102 F. Hoffmann-La Roche Ltd.: Strategic Outlook
Table 103 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 GSK plc: Product Benchmarking
Table 105 GSK plc: Strategic Outlook
Table 106 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Merck & Co. Inc.: Product Benchmarking
Table 108 Merck & Co. Inc.: Strategic Outlook
Table 109 Viatris, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Viatris, Inc.: Product Benchmarking
Table 111 Viatris, Inc.: Strategic Outlook
Table 112 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Novartis AG: Product Benchmarking
Table 114 Novartis AG: Strategic Outlook
Table 115 Pfizer Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Pfizer Inc: Product Benchmarking
Table 117 Pfizer Inc: Strategic Outlook
Table 118 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Sanofi: Product Benchmarking
Table 120 Sanofi.: Strategic Outlook
Table 121 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Teva Pharmaceutical Industries Ltd: Product Benchmarking
Table 123 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 124 Cipla Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Cipla Ltd: Product Benchmarking
Table 126 Cipla Ltd: Strategic Outlook
Table 127 Allergan (AbbVie Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Allergan (AbbVie Inc.): Product Benchmarking
Table 129 Allergan (AbbVie Inc.): Strategic Outlook
Table 130 Cumberland Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Cumberland Pharmaceuticals, Inc.: Product Benchmarking
Table 132 Cumberland Pharmaceuticals, Inc.: Strategic Outlook
Table 133 Lupin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Lupin: Product Benchmarking
Table 135 Lupin: Strategic Outlook
Table 136 Melinta Therapeutics LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Melinta Therapeutics LLC: Product Benchmarking
Table 138 Melinta Therapeutics LLC: Strategic Outlook
Table 139 Amneal Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Amneal Pharmaceuticals LLC: Product Benchmarking
Table 141 Amneal Pharmaceuticals LLC: Strategic Outlook
Table 142 WOCKHARDT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 WOCKHARDT: Product Benchmarking
Table 144 WOCKHARDT: Strategic Outlook

図の一覧
Figure 1 Antibiotics Market Segmentation
Figure 2 Antibiotics Market by Action Mechanism: Market Attractiveness Index
Figure 3 Antibiotics Market by Drug Class: Market Attractiveness Index
Figure 4 Antibiotics Market by Gender: Market Attractiveness Index
Figure 5 Antibiotics Market by Age Group: Market Attractiveness Index
Figure 6 Antibiotics Market by Route of Administration: Market Attractiveness Index
Figure 7 Antibiotics Market: Market Trends
Figure 8 Antibiotics Market: SWOT Analysis
Figure 9 Porter’s Analysis
Figure 10 PEST Analysis
Figure 11 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 12 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 13 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 14 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 15 Antibiotics Market Attractiveness Index by Action Mechanism
Figure 16 Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million)
Figure 17 Antibiotics Market Share Forecast by Action Mechanism, 2023, 2028, 2033 (%)
Figure 18 Cell Wall Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 19 Cell Wall Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Protein Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 21 Protein Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 DNA Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 23 DNA Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 RNA Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 25 RNA Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Mycolic Acid Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 27 Mycolic Acid Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 29 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Antibiotics Market Attractiveness Index by Action Mechanism
Figure 31 Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million)
Figure 32 Antibiotics Market Share Forecast by Drug Class, 2023, 2028, 2033 (%)
Figure 33 Cephalosporin Market Forecast by Region, 2023-2033 (US$ million)
Figure 34 Cephalosporin Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Penicillin Market Forecast by Region, 2023-2033 (US$ million)
Figure 36 Penicillin Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Fluoroquinolone Market Forecast by Region, 2023-2033 (US$ million)
Figure 38 Fluoroquinolone Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Macrolide Market Forecast by Region, 2023-2033 (US$ million)
Figure 40 Macrolide Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Carbapenem Market Forecast by Region, 2023-2033 (US$ million)
Figure 42 Carbapenem Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Aminoglycoside Market Forecast by Region, 2023-2033 (US$ million)
Figure 44 Aminoglycoside Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Sulfonamide Market Forecast by Region, 2023-2033 (US$ million)
Figure 46 Sulfonamide Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 7-ACA Market Forecast by Region, 2023-2033 (US$ million)
Figure 48 7-ACA Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 50 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Antibiotics Market Attractiveness Index by Gender
Figure 52 Antibiotics Market Forecast by Gender, 2023-2033 (US$ million)
Figure 53 Antibiotics Market Share Forecast by Gender, 2023, 2028, 2033 (%)
Figure 54 Male Market Forecast by Region, 2023-2033 (US$ million)
Figure 55 Male Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Female Market Forecast by Region, 2023-2033 (US$ million)
Figure 57 Female Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Antibiotics Market Attractiveness Index by Age Group
Figure 59 Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million)
Figure 60 Antibiotics Market Share Forecast by Age Group, 2023, 2028, 2033 (%)
Figure 61 0-14 Market Forecast by Region, 2023-2033 (US$ million)
Figure 62 0-14 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 15-54 Market Forecast by Region, 2023-2033 (US$ million)
Figure 64 15-54 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 55 years and over Market Forecast by Region, 2023-2033 (US$ million)
Figure 66 55 years and over Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Antibiotics Market Attractiveness Index by Route of Administration
Figure 68 Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 69 Antibiotics Market Share Forecast by Route of Administration, 2023, 2028, 2033 (%)
Figure 70 Oral Market Forecast by Region, 2023-2033 (US$ million)
Figure 71 Oral Market Share Forecast by Region, 2023 & 2033 (%)
Figure 72 Intravenous Market Forecast by Region, 2023-2033 (US$ million)
Figure 73 Intravenous Market Share Forecast by Region, 2023 & 2033 (%)
Figure 74 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 75 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 76 Antibiotics Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 77 Antibiotics Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 78 Antibiotics Market by Region, 2023-2033 (US$ Mn)
Figure 79 North America Antibiotics Market Attractiveness Index
Figure 80 North America Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 81 North America Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 82 North America Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 83 North America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 84 North America Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 85 North America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 86 North America Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 87 North America Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 88 North America Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 89 North America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 90 North America Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 91 North America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 92 North America Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 93 U.S. Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 94 Canada Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 95 Europe Antibiotics Market Attractiveness Index
Figure 96 Europe Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 97 Europe Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 98 Europe Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 99 Europe Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 100 Europe Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 101 Europe Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 102 Europe Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 103 Europe Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 104 Europe Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 105 Europe Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 106 Europe Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 107 Europe Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 108 Europe Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 109 Germany Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 110 UK Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 111 France Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 112 Italy Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 113 Spain Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 114 Russia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 115 Denmark Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 116 Norway Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Sweden Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 118 Finland Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 119 Netherlands Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 120 Rest of Europe Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 121 Asia Pacific Antibiotics Market Attractiveness Index
Figure 122 Asia Pacific Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 123 Asia Pacific Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 124 Asia Pacific Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 125 Asia Pacific Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 126 Asia Pacific Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 127 Asia Pacific Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 128 Asia Pacific Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 129 Asia Pacific Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 130 Asia Pacific Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 131 Asia Pacific Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 132 Asia Pacific Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 133 Asia Pacific Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 134 Japan Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 135 China Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 136 India Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 137 Australia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 138 Singapore Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 139 Malaysia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 140 Sri Lanka Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 141 Rest of Asia Pacific Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 142 Latin America Antibiotics Market Attractiveness Index
Figure 143 Latin America Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 144 Latin America Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 145 Latin America Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 146 Latin America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 147 Latin America Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 148 Latin America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 149 Latin America Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 150 Latin America Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 151 Latin America Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 152 Latin America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 153 Latin America Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 154 Latin America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 155 Latin America Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 156 Brazil Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 157 Mexico Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 158 Argentina Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 159 Colombia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 160 Rest of Latin America Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 161 MEA Antibiotics Market Attractiveness Index
Figure 162 MEA Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 163 MEA Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 164 MEA Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 165 MEA Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 166 MEA Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 167 MEA Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 168 MEA Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 169 MEA Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 170 MEA Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 171 MEA Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 172 MEA Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 173 MEA Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 174 MEA Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 175 GCC Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 176 South Africa Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 177 Rest of MEA Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 178 Abbott Laboratories: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 179 Abbott Laboratories: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 180 Abbott Laboratories: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 181 Abbott Laboratories: Regional Market Share, 2021
Figure 182 Hoffmann-La Roche Ltd.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 183 F. Hoffmann-La Roche Ltd.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 184 F. Hoffmann-La Roche Ltd.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 185 GSK plc: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 186 GSK plc: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 187 GSK plc: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 188 GSK plc: Regional Market Share, 2021
Figure 189 Merck & Co. Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 190 Merck & Co. Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 191 Merck & Co. Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 192 Merck & Co. Inc.: Regional Market Share, 2021
Figure 193 Viatris, Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 194 Viatris, Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 195 Viatris, Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 196 Viatris, Inc.: Regional Market Share, 2021
Figure 197 Novartis AG: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 198 Novartis AG: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 199 Novartis AG: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 200 Novartis AG: Regional Market Share, 2021
Figure 201 Pfizer Inc: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 202 Pfizer Inc: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 203 Pfizer Inc: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 204 Pfizer Inc: Regional Market Share, 2021
Figure 205 Sanofi: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 206 Sanofi: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 207 Sanofi: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 208 Sanofi: Regional Market Share, 2021
Figure 209 Teva Pharmaceutical Industries Ltd: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 210 Teva Pharmaceutical Industries Ltd: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 211 Teva Pharmaceutical Industries Ltd: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 212 Teva Pharmaceutical Industries Ltd: Regional Market Share, 2021
Figure 213 Cipla Ltd: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 214 Allergan (AbbVie Inc.): Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 215 Allergan (AbbVie Inc.): R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 216 Allergan (AbbVie Inc.): Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 217 Allergan (AbbVie Inc.): Regional Market Share, 2021
Figure 218 Cumberland Pharmaceuticals, Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 219 Cumberland Pharmaceuticals, Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 220 Cumberland Pharmaceuticals, Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 221 Amneal Pharmaceuticals LLC: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 222 Amneal Pharmaceuticals LLC: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 223 Amneal Pharmaceuticals LLC: Gross Profit, 2015-2021 (US$ million, AGR%)

ページTOPに戻る

Table of Contents

Summary

Report Details

The Antibiotics Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The global antibiotics market is anticipated to grow owing to the rise in the prevalence of infectious diseases. In addition, the demand is being fuelled by the emergence of innovative methods for new antibiotics for treating bacterial infections, as well as a large number of clinical trials. However, the industry is expected to be hampered by the rise of antibiotic resistance, which is fuelled by antibiotic abuse, as well as the time it takes for regulatory approval. On the other hand, market players across the value chain should expect major profit potential from the development of advanced prospect molecules & novel combination therapies to treat antibiotic-resistant microbial (AMR) infections.

What Questions Should You Ask before Buying a Market Research Report?
• How is the antibiotics market evolving?
• What is driving and restraining the antibiotics market?
• How will each antibiotics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each antibiotics submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading antibiotics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the antibiotics projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
antibiotics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the antibiotics market?
• Where is the antibiotics market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the antibiotics market today, and over the next 10 years:
• Our 388-page report provides 144 tables and 223 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the antibiotics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Action Mechanism
• Cell Wall Synthesis Inhibitors
• Protein Synthesis Inhibitors
• DNA Synthesis Inhibitors
• RNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Others

Drug Class
• Cephalosporin
• Penicillin
• Fluoroquinolone
• Macrolide
• Carbapenem
• Aminoglycoside
• Sulfonamide
• 7-ACA
• Others

Gender
• Male
• Female

Age Group
• 0-14 years
• 15-54 years
• 55 years and over

Route of Administration
• Oral
• Intravenous
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 30 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Denmark
• Norway
• Sweden
• Finland
• Netherlands
• Rest of Europe

Asia Pacific
• Japan
• China
• India
• Australia
• Singapore
• Malaysia
• Sri Lanka
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America

MEA
• GCC
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Antibiotics Market, 2023 to 2033, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• Abbott Laboratories
• Allergan (AbbVie Inc.)
• Amneal Pharmaceuticals LLC
• Cipla Ltd.
• Cumberland Pharmaceuticals, Inc.
• F. Hoffmann-La Roche Ltd.
• GSK plc
• Lupin
• Melinta Therapeutics LLC
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Viatris, Inc.
• WOCKHARDT

Overall world revenue for Antibiotics Market, 2023 to 2033 in terms of value the market will surpass US$46,575 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Antibiotics Market, 2023 to 2033 report help you?
In summary, our 380+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Antibiotics Market, 2023 to 2033 Market, with forecasts for Action Mechanism, Drug Class, Gender, Age Group, and Route of Administration, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.

• Revenue forecasts to 2033 for five regional and 30 key national markets – See forecasts for the Antibiotics Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the Antibiotics Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Antibiotics Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Antibiotics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Market Drivers
3.3.1 Growing Burden of Infectious Diseases to Fuel Market Growth
3.3.2 Adoption of Digital Health Technology to Boost Antibiotics Market Growth
3.3.3 Rising Ageing Population Patient Pool to Drive Growth
3.4 Market Restraints
3.4.1 Strict Regulatory Scenarios to Hamper Market Growth
3.4.2 Rising Antibiotic Resistance to Restrain Market Growth
3.5 Market Opportunities
3.6 SWOT Analysis
3.6.1 Strengths of Antibiotics Market
3.6.2 Weaknesses of Antibiotics Market
3.6.3 Opportunities in Antibiotics Market
3.6.4 Threats in Antibiotics Market
3.7 Industry analysis - Porter’s
3.7.1 Bargaining Power of Buyers (Low)
3.7.2 Bargaining Power of Suppliers (Low)
3.7.3 Intensity of Competitive Rivalry (High)
3.7.4 Threat of Substitute (Low)
3.7.5 Threat of New Entrants (Low)
3.8 PEST Analysis
3.8.1 Political Factors Impacting Antibiotics Market
3.8.1.1 Government Scenario
3.8.1.2 Closed Market
3.8.1.3 Price Control
3.8.2 Economic Factors Impacting Antibiotics Market
3.8.2.1 Growth in Individual Income
3.8.2.2 New Drugs
3.8.2.3 Cost Cutting
3.8.3 Social Factors Impacting Antibiotics Market
3.8.3.1 Generation Health
3.8.3.2 Infectious Diseases
3.8.3.3 Health Consciousness
3.8.4 Technological Factors Impacting Antibiotics Market
3.8.4.1 Biotech Industry Growth
3.8.4.2 Market Penetration
3.9 COVID-19 Impact Analysis

4 Antibiotics Market Analysis by Action Mechanism
4.1 Key Findings
4.2 Action Mechanism Segment: Market Attractiveness Index
4.3 Antibiotics Market Size Estimation and Forecast by Action Mechanism
4.4 Cell Wall Synthesis Inhibitors
4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Protein Synthesis Inhibitors
4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 DNA Synthesis Inhibitors
4.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 RNA Synthesis Inhibitors
4.7.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Mycolic Acid Inhibitors
4.8.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Others
4.9.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.9.2 Market Share by Region, 2023 & 2033 (%)

5 Antibiotics Market Analysis by Drug Class
5.1 Key Findings
5.2 Drug Class Segment: Market Attractiveness Index
5.3 Antibiotics Market Size Estimation and Forecast by Drug Class
5.4 Cephalosporin
5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Penicillin
5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Fluoroquinolone
5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Macrolide
5.7.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Carbapenem
5.8.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Aminoglycoside
5.9.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.9.2 Market Share by Region, 2023 & 2033 (%)
5.10 Sulfonamide
5.10.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.10.2 Market Share by Region, 2023 & 2033 (%)
5.11 7-ACA
5.11.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.11.2 Market Share by Region, 2023 & 2033 (%)
5.12 Others
5.12.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.12.2 Market Share by Region, 2023 & 2033 (%)

6 Antibiotics Market Analysis by Gender
6.1 Key Findings
6.2 Gender Segment: Market Attractiveness Index
6.3 Antibiotics Market Size Estimation and Forecast by Gender
6.4 Male
6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Female
6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)

7 Antibiotics Market Analysis by Age Group
7.1 Key Findings
7.2 Age Group Segment: Market Attractiveness Index
7.3 Antibiotics Market Size Estimation and Forecast by Age Group
7.4 0-14 Years
7.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 15-54 Years
7.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 55 Years and Over
7.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
7.6.2 Market Share by Region, 2023 & 2033 (%)

8 Antibiotics Market Analysis by Route of Administration
8.1 Key Findings
8.2 Route of Administration Segment: Market Attractiveness Index
8.3 Antibiotics Market Size Estimation and Forecast by Route of Administration
8.4 Oral
8.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.4.2 Market Share by Region, 2023 & 2033 (%)
8.5 Intravenous
8.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.5.2 Market Share by Region, 2023 & 2033 (%)
8.6 Others
8.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
8.6.2 Market Share by Region, 2023 & 2033 (%)

9 Antibiotics Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast

10 North America Antibiotics Market Analysis
10.1 Key Findings
10.2 North America Antibiotics Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
10.5 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
10.6 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
10.7 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
10.8 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
10.9 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
10.10 U.S. Antibiotics Market Analysis
10.11 Canada Antibiotics Market Analysis

11 Europe Antibiotics Market Analysis
11.1 Key Findings
11.2 Europe Antibiotics Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
11.5 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
11.6 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
11.7 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
11.8 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
11.9 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
11.10 Germany Antibiotics Market Analysis
11.11 UK Antibiotics Market Analysis
11.12 France Antibiotics Market Analysis
11.13 Italy Antibiotics Market Analysis
11.14 Spain Antibiotics Market Analysis
11.15 Russia Antibiotics Market Analysis
11.16 Denmark Antibiotics Market Analysis
11.17 Norway Antibiotics Market Analysis
11.18 Sweden Antibiotics Market Analysis
11.19 Finland Antibiotics Market Analysis
11.20 Netherlands Antibiotics Market Analysis
11.21 Rest of Europe Antibiotics Market Analysis

12 Asia Pacific Antibiotics Market Analysis
12.1 Key Findings
12.2 Asia Pacific Antibiotics Market Attractiveness Index
12.3 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
12.5 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
12.6 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
12.7 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
12.8 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
12.9 Japan Antibiotics Market Analysis
12.10 China Antibiotics Market Analysis
12.11 India Antibiotics Market Analysis
12.12 Australia Antibiotics Market Analysis
12.13 Singapore Antibiotics Market Analysis
12.14 Malaysia Antibiotics Market Analysis
12.15 Sri Lanka Antibiotics Market Analysis
12.16 Rest of Asia Pacific Antibiotics Market Analysis

13 Latin America Antibiotics Market Analysis
13.1 Key Findings
13.2 Latin America Antibiotics Market Attractiveness Index
13.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
13.5 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
13.6 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
13.7 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
13.8 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
13.9 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
13.10 Brazil Antibiotics Market Analysis
13.11 Mexico Antibiotics Market Analysis
13.12 Argentina Antibiotics Market Analysis
13.13 Colombia Antibiotics Market Analysis
13.14 Rest of Latin America Antibiotics Market Analysis

14 MEA Antibiotics Market Analysis
14.1 Key Findings
14.2 MEA Antibiotics Market Attractiveness Index
14.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
14.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
14.5 Market Size Estimation and Forecast by Action Mechanism, 2023-2033 (US$ Mn)
14.6 Market Size Estimation and Forecast by Drug Class, 2023-2033 (US$ Mn)
14.7 Market Size Estimation and Forecast by Gender, 2023-2033 (US$ Mn)
14.8 Market Size Estimation and Forecast by Age Group, 2023-2033 (US$ Mn)
14.9 Market Size Estimation and Forecast by Route of Administration, 2023-2033 (US$ Mn)
14.10 GCC Antibiotics Market Analysis
14.11 South Africa Antibiotics Market Analysis
14.12 Rest of MEA Antibiotics Market Analysis

15 Company Profiles
15.1 Antibiotics Market: Company Wise Ranking
15.2 Key Strategies Followed by Leading Antibiotics Players
15.2.1 Internationalization
15.2.2 Product Range Breadth
15.2.3 Capability Development
15.2.4 Cost Differentiation
15.2.5 Vertical Integration
15.3 Pipeline Analysis
15.4 Abbott Laboratories
15.4.1 Company Snapshot
15.4.2 Abbott Laboratories Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2015-2021
15.4.3.2 R&D Expenses, 2015-2021
15.4.3.3 Gross Profit, 2015-2021
15.4.3.4 Regional Market Share, 2021
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 F. Hoffmann-La Roche Ltd.
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2015-2021
15.5.3.2 R&D Expenses, 2015-2021
15.5.3.3 Gross Profit, 2015-2021
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 GSK plc
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2015-2021
15.6.3.2 R&D Expenses, 2015-2021
15.6.3.3 Gross Profit, 2015-2021
15.6.3.4 Regional Market Share, 2021
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Merck & Co. Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2015-2021
15.7.3.2 R&D Expenses, 2015-2021
15.7.3.3 Gross Profit, 2015-2021
15.7.3.4 Regional Market Share, 2021
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Viatris, Inc. (Mylan)
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2015-2021
15.8.3.2 R&D Expenses, 2015-2021
15.8.3.3 Gross Profit, 2015-2021
15.8.3.4 Regional Market Share, 2021
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Novartis AG
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2015-2021
15.9.3.2 R&D Expenses, 2015-2021
15.9.3.3 Gross Profit, 2015-2021
15.9.3.4 Regional Market Share
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Pfizer Inc.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2015-2021
15.10.3.2 R&D Expenses, 2015-2021
15.10.3.3 Gross Profit, 2015-2021
15.10.3.4 Regional Market Share, 2021
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Sanofi
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2015-2021
15.11.3.2 R&D Expenses, 2015-2021
15.11.3.3 Gross Profit, 2015-2021
15.11.3.4 Regional Market Share, 2021
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 Teva Pharmaceutical Industries Ltd.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2015-2021
15.12.3.2 R&D Expenses, 2015-2021
15.12.3.3 Gross Profit, 2015-2021
15.12.3.4 Regional Market Share, 2021
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Cipla Ltd.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2015-2021
15.13.4 Product Benchmarking
15.13.5 Strategic Outlook
15.14 Allergan (AbbVie Inc.)
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Financial Analysis
15.14.3.1 Net Revenue, 2015-2021
15.14.3.2 R&D Expenses, 2015-2021
15.14.3.3 Gross Profit, 2015-2021
15.14.3.4 Regional Market Share, 2021
15.14.4 Product Benchmarking
15.14.5 Strategic Outlook
15.15 Cumberland Pharmaceuticals, Inc.
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2015-2021
15.15.3.2 R&D Expenses, 2015-2021
15.15.3.3 Gross Profit, 2015-2021
15.15.4 Product Benchmarking
15.15.5 Strategic Outlook
15.16 Lupin
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking
15.16.4 Strategic Outlook
15.17 Melinta Therapeutics LLC
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Product Benchmarking
15.17.4 Strategic Outlook
15.18 Amneal Pharmaceuticals LLC
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2015-2021
15.18.3.2 R&D Expenses, 2015-2021
15.18.3.3 Gross Profit, 2015-2021
15.18.4 Product Benchmarking
15.18.5 Strategic Outlook
15.19 WOCKHARDT
15.19.1 Company Snapshot
15.19.2 Company Overview
15.19.3 Product Benchmarking
15.19.4 Strategic Outlook

16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players

List of Tables
Table 1 Antibiotics Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 7 Cell Wall Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 8 Protein Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 9 DNA Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 10 RNA Synthesis Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 11 Mycolic Acid Inhibitors Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 12 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 13 Global Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 14 Cephalosporin Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 15 Penicillin Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 16 Fluoroquinolone Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 17 Macrolide Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 18 Carbapenem Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 19 Aminoglycoside Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 20 Sulfonamide Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 21 7-ACA Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 22 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 23 Global Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 24 Male Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 25 Female Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 26 Global Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 27 0-14 Years Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 28 15-54 Years Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 29 55 Years and Over Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 30 Global Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 31 Oral Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 32 Intravenous Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 33 Others Segment Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 34 Global Antibiotics Market Forecast by Region 2023-2033 (US$ mn, AGR%, CAGR%)
Table 35 North America Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 36 North America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 37 North America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 38 North America Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 39 North America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 40 North America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 41 U.S. Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 42 Canada Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 43 Europe Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 44 Europe Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 45 Europe Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 46 Europe Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 47 Europe Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 48 Europe Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 49 Germany Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 50 UK Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 51 France Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 52 Italy Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 53 Spain Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 54 Russia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 55 Denmark Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 56 Norway Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 57 Sweden Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 58 Finland Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 59 Netherlands Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 60 Rest of Europe Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 61 APAC Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 62 APAC Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 63 APAC Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 64 APAC Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 65 APAC Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 66 APAC Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 67 Japan Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 68 China Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 69 India Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 70 Australia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 71 Singapore Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 72 Malaysia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 73 Sri Lanka Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 74 Rest of APAC Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 75 Latin America Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 76 Latin America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 77 Latin America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 78 Latin America Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 79 Latin America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 80 Latin America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 81 Brazil Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 82 Mexico Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 83 Argentina Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 84 Colombia Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 85 Rest of LATAM Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 86 MEA Antibiotics Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 87 MEA Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 88 MEA Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 89 MEA Antibiotics Market Forecast by Gender, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 90 MEA Antibiotics Market Forecast by Age Group, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 91 MEA Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 92 GCC Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 93 South Africa Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 94 Rest of MEA Antibiotics Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 95 Antibiotics Market: Company Ranking
Table 96 Antibiotics Pipeline Analysis
Table 97 Abbott Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Abbott Laboratories: Product Benchmarking
Table 99 Abbott.: Strategic Outlook
Table 100 Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 102 F. Hoffmann-La Roche Ltd.: Strategic Outlook
Table 103 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 GSK plc: Product Benchmarking
Table 105 GSK plc: Strategic Outlook
Table 106 Merck & Co. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Merck & Co. Inc.: Product Benchmarking
Table 108 Merck & Co. Inc.: Strategic Outlook
Table 109 Viatris, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Viatris, Inc.: Product Benchmarking
Table 111 Viatris, Inc.: Strategic Outlook
Table 112 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Novartis AG: Product Benchmarking
Table 114 Novartis AG: Strategic Outlook
Table 115 Pfizer Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Pfizer Inc: Product Benchmarking
Table 117 Pfizer Inc: Strategic Outlook
Table 118 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Sanofi: Product Benchmarking
Table 120 Sanofi.: Strategic Outlook
Table 121 Teva Pharmaceutical Industries Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Teva Pharmaceutical Industries Ltd: Product Benchmarking
Table 123 Teva Pharmaceutical Industries Ltd.: Strategic Outlook
Table 124 Cipla Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 125 Cipla Ltd: Product Benchmarking
Table 126 Cipla Ltd: Strategic Outlook
Table 127 Allergan (AbbVie Inc.): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 128 Allergan (AbbVie Inc.): Product Benchmarking
Table 129 Allergan (AbbVie Inc.): Strategic Outlook
Table 130 Cumberland Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 131 Cumberland Pharmaceuticals, Inc.: Product Benchmarking
Table 132 Cumberland Pharmaceuticals, Inc.: Strategic Outlook
Table 133 Lupin: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 134 Lupin: Product Benchmarking
Table 135 Lupin: Strategic Outlook
Table 136 Melinta Therapeutics LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 137 Melinta Therapeutics LLC: Product Benchmarking
Table 138 Melinta Therapeutics LLC: Strategic Outlook
Table 139 Amneal Pharmaceuticals LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 140 Amneal Pharmaceuticals LLC: Product Benchmarking
Table 141 Amneal Pharmaceuticals LLC: Strategic Outlook
Table 142 WOCKHARDT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 143 WOCKHARDT: Product Benchmarking
Table 144 WOCKHARDT: Strategic Outlook

List of Figures
Figure 1 Antibiotics Market Segmentation
Figure 2 Antibiotics Market by Action Mechanism: Market Attractiveness Index
Figure 3 Antibiotics Market by Drug Class: Market Attractiveness Index
Figure 4 Antibiotics Market by Gender: Market Attractiveness Index
Figure 5 Antibiotics Market by Age Group: Market Attractiveness Index
Figure 6 Antibiotics Market by Route of Administration: Market Attractiveness Index
Figure 7 Antibiotics Market: Market Trends
Figure 8 Antibiotics Market: SWOT Analysis
Figure 9 Porter’s Analysis
Figure 10 PEST Analysis
Figure 11 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 12 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 13 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 14 Antibiotics Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 15 Antibiotics Market Attractiveness Index by Action Mechanism
Figure 16 Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million)
Figure 17 Antibiotics Market Share Forecast by Action Mechanism, 2023, 2028, 2033 (%)
Figure 18 Cell Wall Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 19 Cell Wall Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 20 Protein Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 21 Protein Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 22 DNA Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 23 DNA Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 24 RNA Synthesis Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 25 RNA Synthesis Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Mycolic Acid Inhibitors Market Forecast by Region, 2023-2033 (US$ million)
Figure 27 Mycolic Acid Inhibitors Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 29 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Antibiotics Market Attractiveness Index by Action Mechanism
Figure 31 Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million)
Figure 32 Antibiotics Market Share Forecast by Drug Class, 2023, 2028, 2033 (%)
Figure 33 Cephalosporin Market Forecast by Region, 2023-2033 (US$ million)
Figure 34 Cephalosporin Market Share Forecast by Region, 2023 & 2033 (%)
Figure 35 Penicillin Market Forecast by Region, 2023-2033 (US$ million)
Figure 36 Penicillin Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Fluoroquinolone Market Forecast by Region, 2023-2033 (US$ million)
Figure 38 Fluoroquinolone Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Macrolide Market Forecast by Region, 2023-2033 (US$ million)
Figure 40 Macrolide Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Carbapenem Market Forecast by Region, 2023-2033 (US$ million)
Figure 42 Carbapenem Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Aminoglycoside Market Forecast by Region, 2023-2033 (US$ million)
Figure 44 Aminoglycoside Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Sulfonamide Market Forecast by Region, 2023-2033 (US$ million)
Figure 46 Sulfonamide Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 7-ACA Market Forecast by Region, 2023-2033 (US$ million)
Figure 48 7-ACA Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 50 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Antibiotics Market Attractiveness Index by Gender
Figure 52 Antibiotics Market Forecast by Gender, 2023-2033 (US$ million)
Figure 53 Antibiotics Market Share Forecast by Gender, 2023, 2028, 2033 (%)
Figure 54 Male Market Forecast by Region, 2023-2033 (US$ million)
Figure 55 Male Market Share Forecast by Region, 2023 & 2033 (%)
Figure 56 Female Market Forecast by Region, 2023-2033 (US$ million)
Figure 57 Female Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Antibiotics Market Attractiveness Index by Age Group
Figure 59 Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million)
Figure 60 Antibiotics Market Share Forecast by Age Group, 2023, 2028, 2033 (%)
Figure 61 0-14 Market Forecast by Region, 2023-2033 (US$ million)
Figure 62 0-14 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 63 15-54 Market Forecast by Region, 2023-2033 (US$ million)
Figure 64 15-54 Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 55 years and over Market Forecast by Region, 2023-2033 (US$ million)
Figure 66 55 years and over Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Antibiotics Market Attractiveness Index by Route of Administration
Figure 68 Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million)
Figure 69 Antibiotics Market Share Forecast by Route of Administration, 2023, 2028, 2033 (%)
Figure 70 Oral Market Forecast by Region, 2023-2033 (US$ million)
Figure 71 Oral Market Share Forecast by Region, 2023 & 2033 (%)
Figure 72 Intravenous Market Forecast by Region, 2023-2033 (US$ million)
Figure 73 Intravenous Market Share Forecast by Region, 2023 & 2033 (%)
Figure 74 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 75 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 76 Antibiotics Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 77 Antibiotics Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 78 Antibiotics Market by Region, 2023-2033 (US$ Mn)
Figure 79 North America Antibiotics Market Attractiveness Index
Figure 80 North America Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 81 North America Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 82 North America Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 83 North America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 84 North America Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 85 North America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 86 North America Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 87 North America Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 88 North America Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 89 North America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 90 North America Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 91 North America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 92 North America Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 93 U.S. Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 94 Canada Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 95 Europe Antibiotics Market Attractiveness Index
Figure 96 Europe Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 97 Europe Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 98 Europe Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 99 Europe Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 100 Europe Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 101 Europe Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 102 Europe Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 103 Europe Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 104 Europe Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 105 Europe Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 106 Europe Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 107 Europe Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 108 Europe Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 109 Germany Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 110 UK Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 111 France Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 112 Italy Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 113 Spain Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 114 Russia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 115 Denmark Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 116 Norway Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Sweden Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 118 Finland Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 119 Netherlands Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 120 Rest of Europe Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 121 Asia Pacific Antibiotics Market Attractiveness Index
Figure 122 Asia Pacific Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 123 Asia Pacific Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 124 Asia Pacific Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 125 Asia Pacific Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 126 Asia Pacific Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 127 Asia Pacific Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 128 Asia Pacific Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 129 Asia Pacific Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 130 Asia Pacific Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 131 Asia Pacific Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 132 Asia Pacific Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 133 Asia Pacific Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 134 Japan Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 135 China Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 136 India Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 137 Australia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 138 Singapore Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 139 Malaysia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 140 Sri Lanka Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 141 Rest of Asia Pacific Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 142 Latin America Antibiotics Market Attractiveness Index
Figure 143 Latin America Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 144 Latin America Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 145 Latin America Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 146 Latin America Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 147 Latin America Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 148 Latin America Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 149 Latin America Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 150 Latin America Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 151 Latin America Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 152 Latin America Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 153 Latin America Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 154 Latin America Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 155 Latin America Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 156 Brazil Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 157 Mexico Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 158 Argentina Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 159 Colombia Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 160 Rest of Latin America Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 161 MEA Antibiotics Market Attractiveness Index
Figure 162 MEA Antibiotics Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 163 MEA Antibiotics Market Forecast by Country, 2023-2033 (US$ million, AGR%)
Figure 164 MEA Antibiotics Market Share Forecast by Country, 2023 & 2033 (%)
Figure 165 MEA Antibiotics Market Forecast by Action Mechanism, 2023-2033 (US$ million, AGR%)
Figure 166 MEA Antibiotics Market Share Forecast by Action Mechanism, 2023 & 2033 (%)
Figure 167 MEA Antibiotics Market Forecast by Drug Class, 2023-2033 (US$ million, AGR%)
Figure 168 MEA Antibiotics Market Share Forecast by Drug Class, 2023 & 2033 (%)
Figure 169 MEA Antibiotics Market Forecast by Gender, 2023-2033 (US$ million, AGR%)
Figure 170 MEA Antibiotics Market Share Forecast by Gender, 2023 & 2033 (%)
Figure 171 MEA Antibiotics Market Forecast by Age Group, 2023-2033 (US$ million, AGR%)
Figure 172 MEA Antibiotics Market Share Forecast by Age Group, 2023 & 2033 (%)
Figure 173 MEA Antibiotics Market Forecast by Route of Administration, 2023-2033 (US$ million, AGR%)
Figure 174 MEA Antibiotics Market Share Forecast by Route of Administration, 2023 & 2033 (%)
Figure 175 GCC Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 176 South Africa Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 177 Rest of MEA Antibiotics Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 178 Abbott Laboratories: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 179 Abbott Laboratories: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 180 Abbott Laboratories: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 181 Abbott Laboratories: Regional Market Share, 2021
Figure 182 Hoffmann-La Roche Ltd.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 183 F. Hoffmann-La Roche Ltd.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 184 F. Hoffmann-La Roche Ltd.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 185 GSK plc: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 186 GSK plc: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 187 GSK plc: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 188 GSK plc: Regional Market Share, 2021
Figure 189 Merck & Co. Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 190 Merck & Co. Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 191 Merck & Co. Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 192 Merck & Co. Inc.: Regional Market Share, 2021
Figure 193 Viatris, Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 194 Viatris, Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 195 Viatris, Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 196 Viatris, Inc.: Regional Market Share, 2021
Figure 197 Novartis AG: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 198 Novartis AG: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 199 Novartis AG: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 200 Novartis AG: Regional Market Share, 2021
Figure 201 Pfizer Inc: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 202 Pfizer Inc: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 203 Pfizer Inc: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 204 Pfizer Inc: Regional Market Share, 2021
Figure 205 Sanofi: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 206 Sanofi: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 207 Sanofi: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 208 Sanofi: Regional Market Share, 2021
Figure 209 Teva Pharmaceutical Industries Ltd: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 210 Teva Pharmaceutical Industries Ltd: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 211 Teva Pharmaceutical Industries Ltd: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 212 Teva Pharmaceutical Industries Ltd: Regional Market Share, 2021
Figure 213 Cipla Ltd: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 214 Allergan (AbbVie Inc.): Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 215 Allergan (AbbVie Inc.): R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 216 Allergan (AbbVie Inc.): Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 217 Allergan (AbbVie Inc.): Regional Market Share, 2021
Figure 218 Cumberland Pharmaceuticals, Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 219 Cumberland Pharmaceuticals, Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 220 Cumberland Pharmaceuticals, Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 221 Amneal Pharmaceuticals LLC: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 222 Amneal Pharmaceuticals LLC: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 223 Amneal Pharmaceuticals LLC: Gross Profit, 2015-2021 (US$ million, AGR%)

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（抗生物薬）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（administration oral）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

抗生物質市場レポート：2023-2033

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（抗生物薬）の最新刊レポート

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（administration oral）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?